£250k
+7%vs Jun 2024Active08102507Private limited companyLondon
AMAXA PHARMA LTD
Significant control: Vladimir Tkachenko (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Amaxa Pharma Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMAXA PHARMA LTD is an active private limited company (company number 08102507) incorporated on 12 June 2012, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £250k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 7% on the prior period (£233k).
Peer position · net assets
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Ownership and control
- Mr Vladimir Tkachenko
- has significant influence or control
- Mr Vladimir Tkachenko
- has significant influence or control
- Ms. Jane Tkachenko
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 June 201214 yrs ago
- Next accounts due
- 30 March 2027in 158 days
- Confirmation statement due
- 26 June 2027in 246 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £250k | — | — | £177k | — | — | 1 |
| 30 June 2024 | £233k | — | — | £371k | — | — | 1 |
Current ratio2.09Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £250,479 at 30 June 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.09
- Incorporated five or more years agoIncorporated 12 June 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 246 days
- Next accounts duein 158 days
- Accounts period endNet assets £250k · micro accounts
- Accounts period endNet assets £233k · micro accounts
- Incorporated
08
Similar companies in London
- AEGERION PHARMACEUTICALS LIMITEDLondon · inc. Jun 2012
- KOOL PHARMA LIMITED45 Gresham Street · inc. Jul 2012
- HNS PHARMA LIMITEDForest Hill · inc. Apr 2012
- THLALA KOLO (UK) LTDLondon · inc. Mar 2012
- MITOCHONDRIAL THERAPY LTDLondon · inc. Feb 2012
- CURIECHEM LTDLondon · inc. Oct 2012
All companies incorporated on 12 June 2012 · in Jun 2012.
09
Reminders for AMAXA PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.